Does a Defibrillator Hurt? What the Shock Feels Like

Explore the experience of a defibrillator shock, understanding its critical role in cardiac emergencies and what happens during this life-saving procedure.

A defibrillator shock hurts, and most people who have experienced one remember it vividly. In surveys, roughly four out of five implantable cardioverter-defibrillator (ICD) patients rate the sensation between moderate and severe, commonly comparing it to a hard blow to the chest or a sudden, involuntary whole-body spasm. The pain is brief but intense, and the context matters enormously: whether the shock comes from an implanted device, an external defibrillator in a hospital, or paddles during an emergency all change the experience in ways worth understanding.

How Patients Describe the Sensation

People who receive ICD shocks tend to reach for physical analogies. In one study of ICD recipients asked to rate shock severity on a one-to-five scale, 79% scored it between three and five. The most frequent descriptions were “a blow to the body” and “a spasm causing the entire body to jump.” Others have compared it to being kicked in the chest by a horse, or to sticking a finger in a light socket but feeling it everywhere at once. The sensation lasts less than a second, but it arrives without warning, which amplifies how jarring it feels. Some patients describe a metallic taste in the mouth immediately afterward, while others report a brief feeling of lightheadedness or disorientation that fades within seconds to minutes.

An important nuance: despite rating the shocks as severe, most patients in the same study said they tolerated them because they understood the device had just saved their life. That psychological framing, knowing the pain was the cost of surviving a lethal arrhythmia, shapes how people process the experience over time. It does not erase the pain, but it contextualizes it in a way that matters for coping.

Why Defibrillator Shocks Are Painful

The pain is not coming from your heart. When a defibrillator fires, the electrical pulse travels between the device’s electrodes and passes through the heart muscle to reset its rhythm. But that current also spreads into surrounding skeletal muscles and the nerves that supply them, particularly in the chest wall and upper abdomen. The involuntary contraction of those muscles, and the nerve fibers firing along with them, is what produces the sharp, convulsive pain people feel. Researchers have been working for years to develop shock waveforms that deliver enough energy to defibrillate the heart while activating as little surrounding muscle as possible. Progress has been real, but the fundamental problem remains: you cannot push a high-energy pulse through the chest without some of it reaching tissue you would rather leave alone.

External Cardioversion Is Different

If your doctor schedules a cardioversion, where external paddles or patches deliver a shock to correct an arrhythmia like atrial fibrillation, you will be sedated first. A Cochrane review of studies involving hundreds of patients found that sedation or general anesthesia is standard for the procedure specifically because the shock is painful and distressing if felt consciously. Across sixteen studies measuring patient awareness or recall, nearly all participants had no memory of the shock itself. That said, the energy levels used in external cardioversion are substantially higher than those used by implanted devices. External shocks can exceed 200 or even 360 joules, while an ICD delivers somewhere between 25 and 40 joules internally. Sedation is not a luxury here; it is a medical necessity.

Awareness during ICD-related procedures is rare but documented. In one report, two out of thirty-three patients recalled feeling defibrillation shocks delivered during device implantation testing, despite receiving anesthesia. For day-to-day ICD shocks that fire in response to a real arrhythmia, though, there is no sedation. The device fires automatically, and you feel it.

Skin Burns and Soreness Afterward

The shock itself lasts a fraction of a second, but its aftermath can linger. With external cardioversion, the skin under the paddles or electrode patches frequently shows signs of injury. One study found that 84% of patients experienced some pain at the paddle sites, and 23% reported moderate to severe skin pain. Burns were worse at the edges of the electrodes than at the center, and worse at the sternal (chest-front) site than the side position. Biopsies taken 24 hours after cardioversion have confirmed that these are first-degree burns, essentially sunburn-like injuries in the skin, and their severity increases with higher shock energy levels.

For implanted devices, the physical aftermath is different. The shock is delivered internally, so there are no skin burns in the usual sense. But patients who receive multiple shocks in succession can develop tenderness and swelling at the implant site. In one documented case involving repeated ICD discharges, examination revealed noticeable swelling and tenderness over the device pocket. Chest wall muscle soreness lasting hours to a day or two is common after an ICD shock, similar to the feeling after an intense, involuntary muscle cramp.

Anti-Tachycardia Pacing Can Prevent the Shock Entirely

Not every dangerous heart rhythm needs a high-voltage jolt to stop it. Modern ICDs are programmed to try a gentler approach first: anti-tachycardia pacing, or ATP. Instead of delivering a full shock, the device sends a rapid series of small electrical pulses that attempt to outpace the arrhythmia and reset the heart to normal rhythm. You typically do not feel ATP at all, or you notice only a mild flutter.

The results have been impressive. In one study of patients with fast ventricular tachycardia, a standardized ATP protocol terminated 89% of episodes without needing a shock. A multicenter trial confirmed these findings and emphasized that careful device programming to maximize ATP use is one of the most effective ways to reduce the number of painful shocks a patient receives over the life of the device. ATP does not work for all arrhythmias, and in a small fraction of cases it can accelerate an episode rather than stop it, which then triggers a shock anyway. But for the majority of fast ventricular tachycardias, it is a painless first line of defense.

Shocks That Should Not Have Happened

One of the most frustrating experiences for ICD patients is receiving a shock when nothing was actually wrong, or at least nothing that warranted a full defibrillation. These “inappropriate shocks” happen when the device misinterprets a non-dangerous rhythm, like atrial fibrillation with a fast heart rate or electrical noise from a loose lead, as a life-threatening arrhythmia. In a large study tracking ICD patients over an average of about three and a half years, 13% received at least one inappropriate shock, and the rate climbed to 18% at five years. Having a history of atrial fibrillation roughly doubled the risk.

These shocks feel identical to appropriate ones. The device does not deliver a softer shock because it made an error. From the patient’s perspective, they are hit with the full force of a defibrillation for no reason. In rare cases, inappropriate shocks have even triggered dangerous rhythms that then required a real shock, compounding the physical and emotional trauma. Improved programming algorithms and dual-chamber devices have reduced inappropriate shock rates over time, but they have not been eliminated.

Waveform Design Has Reduced Pain

The type of electrical waveform a defibrillator uses affects how much it hurts. Older devices used monophasic waveforms, which push current in one direction. Modern devices overwhelmingly use biphasic waveforms, which reverse the current partway through the pulse. This technical shift has had a direct effect on patient comfort. In a randomized trial comparing the two waveform types for external cardioversion of atrial fibrillation, biphasic shocks required dramatically less energy to restore normal rhythm and produced significantly less patient-reported pain both one hour and twenty-four hours after the procedure. Less energy means less current spreading into skeletal muscle, which means less of the convulsive pain people dread.

Strategies for Reducing Shock Frequency

Beyond ATP and waveform improvements, two main strategies exist for cutting down on the number of shocks a patient receives: antiarrhythmic medications and catheter ablation. A systematic review and meta-analysis of randomized trials found that the drug amiodarone cut ICD shock rates by roughly two-thirds compared with control, while catheter ablation cut them by about half. A landmark trial found that patients who received catheter ablation at the time of ICD implantation had dramatically fewer shocks: only 9% received shocks during follow-up versus 31% in the group that received the ICD alone.

For patients who have already experienced recurrent shocks despite drug therapy, ablation has also shown benefits over simply escalating medication doses. One trial comparing ablation to escalated antiarrhythmic drugs found that ablation reduced the combined risk of death, ventricular tachycardia storm, and ICD shock compared with intensifying medication. None of these approaches eliminates shocks entirely, but they collectively explain why many ICD patients today go years without ever being shocked.

The Psychological Weight of Living with Shocks

The physical pain of a shock is over in under a second. The psychological impact can last much longer. A meta-analysis covering nearly 40,000 ICD patients found post-traumatic stress disorder in about 12% of the overall ICD population. Among those who have actually received shocks, the rate climbs to around 20%. Anticipatory anxiety is common: patients report restructuring their lives around the fear of another shock, avoiding exercise, driving less, and withdrawing from social activities.

Structured psychological support helps. A randomized trial of a cognitive-behavioral program specifically designed for ICD patients who had been shocked found that it reduced psychological distress and improved quality of life, whether delivered in group or individual format. Cognitive-behavioral therapy, structured patient education before implantation, and transparent communication about device alerts and recalls have all shown effectiveness. Despite this, many patients report feeling they received inadequate preparation before the device was placed.

Phantom Shocks

Some ICD patients report feeling shocks when device interrogation confirms none were delivered. These phantom shocks occur in roughly 5% of ICD recipients and are more common in the first six months after implantation, particularly at night. They are not the device malfunctioning, and the patient is not imagining things out of nowhere. The sensation appears to be a real perceptual experience produced by the brain, likely driven by anxiety, heightened body vigilance, and the trauma of previous real shocks. Patients who have experienced actual shocks are far more likely to report phantom ones: in one study, 34% of patients who had received real shocks also reported phantoms, compared with essentially none among those who had never been shocked.

Phantom shocks are associated with higher levels of depression and anxiety, and patients who report them are more likely to say they received insufficient information before the device was implanted and that they need psychological support. The phenomenon is also more common at night, which aligns with evidence linking it to anxiety-driven hyperarousal. If you have an ICD and feel a shock, always have the device interrogated. But knowing that phantom shocks are a well-documented phenomenon can itself be reassuring.

Gender Differences in Shock Anxiety

Women with ICDs consistently report higher levels of anxiety and device-related concern than men. In one study that adjusted for demographic and clinical differences, women were more than twice as likely as men to score in the high-anxiety range, and they reported significantly more ICD-specific concerns. Having received a shock elevated anxiety levels for both sexes, but the baseline gap meant women who had been shocked were dealing with compounded distress. Depression and device acceptance did not differ significantly between men and women, suggesting the gap is specifically about anxiety and worry rather than overall emotional well-being. Some researchers have pointed out that clinical ICD trials have historically enrolled far more men than women, which may mean that counseling approaches and patient education materials are implicitly calibrated to male experiences.

Wearable Defibrillator Vests

Wearable cardioverter-defibrillators, sometimes prescribed as a temporary bridge while waiting for an ICD implant or during a recovery period, deliver external shocks through electrode pads worn against the skin. They present their own discomfort profile even before a shock occurs. In a preliminary quality-of-life study, 37% of patients wearing the vest reported pain or discomfort from the garment itself, 48% had sleep disturbances, 29% feared receiving a shock, and 43% reported mental health issues during the time they wore the device. The vest alerts the wearer with alarms and vibrations before delivering a shock, giving a conscious patient a few seconds to press a response button and abort delivery if they feel fine. That warning interval distinguishes it from an ICD, which fires without notice, but it introduces its own form of stress: the alarm itself triggers panic in some patients, particularly during false activations.

Children and Teenagers with ICDs

Pediatric ICD patients face a distinct set of challenges. Children who received their device after surviving a cardiac arrest were far more likely to meet criteria for PTSD than those who received one for prevention: in one study, 83% of secondary-prevention pediatric patients met PTSD criteria compared with 17% of primary-prevention patients. Interestingly, in that same study, having received a shock did not on its own significantly predict whether a child developed PTSD. What mattered more was the broader medical trauma experience and whether the child had been through a life-threatening event. Children with PTSD did, however, report significantly higher shock anxiety scores even if they had never been shocked, suggesting that anticipatory fear of the device itself can be as damaging as the shocks. Pediatric cardiology programs increasingly incorporate psychological screening and family-based interventions, recognizing that the device’s psychological footprint on a developing child can extend well beyond the physical experience of a shock.